Archive | Health & Innovation RSS feed for this section

Life Science Nation and YAFO Capital Announce ACCESS CHINA Forum (Spring 2021) – China Innovation Out-Licensing Event at Healthtech Partnering Week

25 Feb

By Dennis Ford, Founder and CEO of Life Science Nation, Creator of the RESI Conference Series

In 2021, Life Science Nation (LSN) launched the digital Healthtech Partnering Week (HPW), which consists of the renowned digital Redefining Early Stage Investments (RESI) 3-day event, 4D Meets AI 2-day event, and the Longevity, Health & Innovation (LHI) 2-day event, and now introducing ACCESS CHINA 2-day forum. LSN introduced this new open-concept conference theme in order that other independent conferences could participate in the week-long event with access to LSN’s premier partnering capability, which matches early-stage companies with strategic investment and licensing partners. HPW welcomes global partnering events to leverage the LSN global partner network, providing an incredible value to all attendees.

YAFO Capital‘s ACCESS CHINA Forum is a quarterly corporate access event series between China and Western biopharma. It is a leading deal-making platform for Western pharma and biotech leaders looking to enter or expand in the Chinese market, and for Chinese companies to enter the global market. ACCESS CHINA Spring Forum, which focuses on China biotech innovation and out-licensing opportunities, adds to the HPW momentum. The Forum creates a great opportunity for LSN’s buy-side global partner network of investors, pharma and corporate strategics seeking equity and licensing opportunities to look at elite technology assets coming out of Asia. The scientist-entrepreneurs and fundraising CEOs coming to HPW via ACCESS CHINA Forum will be able to make new connections with global partners that will help them transition from their regional markets to the global arena.

LSN welcomes any firm that has a standalone life science partnering event happening simultaneously with HPW to join forces. YAFO Capital’s ACCESS CHINA Forum is a great example of how we can work together and deliver elite technology assets to a broader investor and strategic partner audience. Our goal is to reach across borders and events to raise the tide of early-stage partnering and lift all fundraising efforts in order to advance the latest in life-saving technologies and healthcare treatments.

Sign up to join Healthtech Partnering Week and take advantage of our global network of partners!

Free Webinar: Strategies for Successful Partnering

25 Feb

By Karen Deyo, Director of Investor Research, Israel BD, LSN

Life Science Nation (LSN) has recently held two free webinars outlining strategies for successful partnering. Whether new to LSN and our early stage partnering events, or a frequent participant seeking to optimize their experience, it’s our goal that you have access to learn how to use the platform well, so you can spend more time meeting investors and making deals.

Healthtech Partnering Week (HPW) launches March 15-19, and there’s still time to sign up and even apply for the Innovator’s Pitch Challenge (IPC) – applications are due tomorrow, February 26! If you’re an early stage fundraising executive unsure of what makes a powerful partnering platform, we invite you to watch our latest webinar on strategies for success partnering. Learn more and sign up at https://www.healthtechpartneringweek.com/.

Getting it Right from Pitch to Partner

18 Feb

By Karen Deyo, Director of Investor Research, Israel BD, LSN

As each Life Science Nation event approaches, we spend a lot of time and effort to help startups achieve the best possible outcome through partnering. We have published many articles detailing why partnering is important, how to get ready for your outreach, how to get as many meetings as possible and how to prepare for them.

As we gear up to launch Digital RESI partnering next week, we are offering a free tutorial to help founders make the most of the partnering experience. But what steps can you take to make your meeting successful, to improve your chances of a follow up meeting? Here are a few tips that can help!

  1. Know your audience.

We frequently give this advice, both when requesting meetings and when preparing for them. Your meeting will be different, depending on whether you are speaking to a VC, an angel group or a strategic partner. What are they looking for? This can give you the key to making yourself stand out. Make use of online resources to know the investor with whom you are meeting, the organization and their portfolio companies, such as their website, LinkedIn or Crunchbase, among others. The more info you have, the better you can focus on what about your company will spark their interest.

  1. During the meeting, make it a discussion – not a presentation.

In our experience, companies that approach meetings as a discussion with the investor, as opposed to a pitch running through their deck, meet with better responses. Investors see a lot of pitches, and you want to be able to translate your enthusiasm for your company – this does not translate well when simply running through your deck. Engage the investor in a conversation and make it dynamic. However, remember to be grounded: it is important to be passionate, but be realistic about your technology. Not every company is founded on first-in-class science. Improvements to current treatment paradigms can be just as successful and may be more attractive to some investors due to the decreased risk, so don’t oversell yourself.

  1. Know which areas of your company/technology to highlight.

No one knows your company, or your story, better than you. Give the investors a concise (but complete) overview of your company. You know what makes your company stand out, whether it is the story behind the company, the technology, the team, or the application – make sure to highlight this. Also, make sure the investor knows what milestones you have already achieved and, more importantly, how much you are raising and what milestones you plan to hit with these funds.

  1. Know what questions to ask the investor.

The investor will certainly ask you questions that you should be prepared to answer, but you should also think about what questions you want to ask the investor. Gaining an investor is like entering a long-term relationship – you want to make sure that you can work well together, potentially for years to come. In addition, many investors are more than just financial contributors. It is key to find out how involved the investor chooses to be after investing: do they take a board seat? Will they leverage their network or connections for you? For a strategic partner, do they have an infrastructure that could benefit your development? As with the previous tips, this is where knowing your audience can play a big role, as your questions will change depending on the investor. You may ask a traditional VC about their desired timeline to exit, but you would likely ask a Corporate VC about how connected the parent company is to their deals.

The more prepared you are, the greater your chance of success. Fundraising is not only a numbers game, but it can also be a full-time job. By doing what you can to shorten the fundraise, you can increase your time to focus on the most important aspect of your job – building a successful company!

Sign up for our free partnering tutorial, Tuesday, February 23, 12 PM EST.

There is still time to sign up for Healthtech Partnering Week at the early-bird rate. Sign up by February 19 and SAVE!

Healthtech Partnering Week Preliminary Speaker Lineup

11 Feb

By Rory McCann, Marketing Manager & Conference Producer, LSN

Healthtech Partnering Week, March 15-19, is right around the corner! The 5-day digital partnering event consists of three conferences focusing on different areas within life science and healthcare. Redefining Early Stage Investments (RESI) broadly covers investor insights for fundraising executives within healthtech, biotech, and medtech. 4D Meets AI specifically tackles the investor-founder relationship, from pitch to partner, while working with AI technology in drugs, devices, diagnostics, and digital health (4Ds). Longevity, Health & Innovation, co-organized with Mary Furlong & Associates, provides a big-picture approach to the investment ecosystem, as well as market overview and regulatory landscape for early-stage age-tech and innovation enabling seniors to live longer, better lives.

Life Science Nation (LSN) is pleased to introduce our preliminary speaker lineup, featuring investors and industry experts sharing their experiences and offering insights to help fundraising companies succeed in the early stages.

Interested in joining a panel? Visit www.healthtechpartneringweek.com to learn more about each conference. Fundraising in 2021, and looking to meet with active investors? Join us and save on our early-bird rates by February 19!

Featured Healthtech Partnering Week Panelists


Sascha Berger
Partner
TVM Capital Life Science

Diagnostics


Jean Anne Booth
CEO
UnaliWear Inc.

Devices


Nat Brinn
Partner
VC23

Tools and R&D Services


Barbara Clarke
Founder & President
The Impact Seat

Investing in New, Now, and Next


Evan Cohen
Associate Principal, Strategic Investing
Healthbox

Digital Health for the Elderly


Michele Colucci
Managing Partner
DigitalDx Ventures

Diagnostics


Terence Craig
Chief Investment Officer
The Impact Seat

Devices


Bettina Ernst
Director
BERNINA BioInvest

Investing in New, Now, and Next


Howard Fillit
Founding Executive Director and CSO
Alzheimers Drug Discovery Foundation

Early Detection of CNS Disorders


Robert Garber
Partner
7wire Ventures

Investing in New, Now, and Next


Amit Garg
Managing Partner
Tau Ventures

Digital Health


Scott Gazelle
Managing Partner
GreyBird Ventures

Diagnostics


Tom Gibbs
Director
Debiopharm Innovation Fund

Digital Health


Katherine Hill Ritchie
Director
Nottingham Spirk Family Office

Medical Devices


Alicia Irurzun-Lafitte
Partner
UCB Ventures

Cell & Gene Therapy


Justin Kelly
Associate
AXA Venture Partners

Digital Health for the Elderly


Oliver Keown
Director, Intuitive Ventures
Intuitive Surgical

Combination Devices


Lily Kim
Scientific Director
OS Fund

Tools and R&D Services


Kristin King
Member
Boston Harbor Angels

Medical Devices


Richard Kivel
Managing Director
GrayBella Capital

Diagnostics


Daniella Kranjac
Founding Partner
Dynamk Capital

Tools and R&D Services


Taja Lester
Managing Partner
Health Equity Capital

Digital Health for the Elderly


George Li
Managing Partner
Proxima Ventures

Diagnostics


Jonathan Ng
CEO
Iterative Scopes

Digital Health


Jeffrey Ries
Managing Director
Healthbox

Digital Health


Kerry Rupp
General Partner
True Wealth Ventures

Digital Health for the Elderly


Chirag Shah
Principal
Define Ventures

Digital Health


Patrik Sobocki
Investment Manager Life Science
Industrifonden

Digital Health


Catello Somma
Associate
TVM Capital Life Science

Early Stage Therapeutics


Weiyong Sun
Senior Director, Specialty Medicine Search & Evaluation
Daiichi Sankyo

Cell & Gene Therapy


Tad Weems
Managing Director
Agilent Technologies

Tools and R&D Services

Best Practices in Conference Partnering: Join Our Free Webinar

11 Feb

 

By Karen Deyo, Director of Investor Research, Israel BD, LSN

Life Science Nation (LSN)’s mission is to connect early-stage companies in life science and healthcare with investment capital that is a fit based on product and stage of development. LSN’s partnering system is unique in that it contains search functionality to help fundraising executives narrow down to the best investors for their needs, removing the question, “Is this a good fit?”

While LSN cannot make the deal for you, we can help you connect with the contacts you need to succeed in your raise and growth. We can also prepare you with tried-and-true tips to make your partnering experience exceptional, letting your technology, product, and team take center-stage as you pitch to investors.

Sign up for our free webinar, Strategies for Successful Partnering, taking place February 17, 12 PM EST. Whether Seed or Series B, our methods have assisted early-stage companies in raising millions of dollars, and we hope to add yours to our growing list of success stories!

Are you fundraising and looking to meet with investors who fit your product set and stage of development? Sign up for Healthtech Partnering Week, March 15-19, by February 19 to save on early-bird rates!

Workshops at Healthtech Partnering Week

11 Feb

By Gregory Mannix, Vice President International Business Development, LSN

Workshops at Healthtech Partnering Week are live webinars designed to educate leaders of fundraising companies on elements of the early-stage landscape often overlooked, which can include patents, recruitment, intellectual property, insurance, financial management, and so much more. Check out some of the great content coming your way this March:

Venture Valuation provides global valuation services by assessing companies and products. Founded in 1999 by Dr. Patrik Frei, Venture Valuation has done over 700 valuations for biotech, pharma, and medtech companies around the world, and supports companies’ growth with entrepreneurial education and industry insight.

The Venture Valuation team is bringing their expertise to Healthtech Partnering Week, March 15-19 with two workshops: Company Valuation for Fundraising and Product Valuation for Deal-Making. Each workshop is designed to provide early-stage founders with practical insight into financing and licensing trends, valuation approaches, licensing negotiations, and finding the right investors and strategic partners.

These skills are a necessary component to the growth of early-stage companies, and we invite all start-ups in life science and healthcare to get to know the Venture Valuation team and take advantage of their expertise by joining us at Healthtech Partnering Week.

Sign up to save on early-bird rates by February 19!

Patrik Frei, PhD
CEO
Venture Valuation

Gergely Ivanyi, PharmD
Business Analyst
Venture Valuation

Elias Neuendorf, MSc
Business Analyst
Venture Valuation

Company Valuation for Fundraising

Instructors: Patrik Frei, PhD, CEO, Venture Valuation
Gergely Ivanyi, PharmD, Business Analyst, Venture Valuation
Valuation is a key aspect of fundraising. An average value assumption for each company in a specific financing stage just does not do it anymore. For entrepreneurs, as for investors, it’s important to understand the value drivers of a company. We are looking at the financing trends of the last years, discuss dos and don’ts when speaking with investors and look at how to value a life science company with no revenues.

Topics include, but are not limited to:

    • Overview financing trends
  • Which is the right investor?
  • Dos and don’ts
  • Company valuation approaches

Product Valuation for Deal-Making

Instructors: Patrik Frei, PhD, CEO, Venture Valuation
Elias Neuendorf, MSc, Business Analyst, Venture Valuation
Companies looking at in- or out-licensing need to understand the value dynamics of their product to negotiate realistic deal-terms. Successful business development depends on understanding the fundamentals as well as keeping up with the latest licensing deal trends. We will be looking at the latest deals including up-front and total deal values for different stages and indications and discuss the fundamental valuation approach to asset/product valuation as a basis to estimate possible licensing deal terms.

Topics include, but are not limited to:

  • Overview licensing deal and trends
  • How to find the right licensing partner
  • Asset/Product valuation approach
  • Licensing deal negotiation

If you’re interested in hosting a workshop or panel at Healthtech Partnering Week, our Business Development Team is happy to learn more in order to meet your goals. Contact us to start the conversation!

Fill Your Fundraising Dance Card with These Investors

4 Feb

By Rory McCann, Marketing Manager & Conference Producer, LSN

For more than eight years, Life Science Nation (LSN) has hosted the go-to partnering events that have provided attendees with what they seek most, but rarely get with networking conferences: a well-matched meeting. LSN’s premier partnering system has helped raise millions of dollars for early-stage companies in life science and healthcare by matching fundraising founders with investors and strategic partners based on product fit and stage of development.

Healthtech Partnering Week (HPW), March 15-19 is right around the corner, and we are thrilled to host enthusiastic, active investors and service providers passionate about advancing products and services that help patients live well. Check out our growing list of confirmed investors joining us and sign up by February 19 to save on our early bird rates.

Confirmed HPW Investors

Confirmed RESI Investors Confirmed 4D Meets AI Investors Confirmed LHI Investors

 

 

%d bloggers like this: